Jonathan C Javitt - Net Worth and Insider Trading
Jonathan C Javitt Net Worth
The estimated net worth of Jonathan C Javitt is at least $2 Million dollars as of 2024-11-08. Jonathan C Javitt is the Chief Scientist, 10% Owner of NRX Pharmaceuticals Inc and owns about 1,476,833 shares of NRX Pharmaceuticals Inc (NRXP) stock worth over $2 Million. Details can be seen in Jonathan C Javitt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jonathan C Javitt has not made any transactions after 2023-08-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jonathan C Javitt
Jonathan C Javitt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jonathan C Javitt owns 3 companies in total, including Brainstorm Cell Therapeutics Inc (BCLI) , NextGen Healthcare Inc (NXGN) , and NRX Pharmaceuticals Inc (NRXP) .
Click here to see the complete history of Jonathan C Javitt’s form 4 insider trades.
Insider Ownership Summary of Jonathan C Javitt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics Inc | 2008-08-27 | director |
| NXGN | NextGen Healthcare Inc | 2004-09-21 | director |
| NRXP | NRX Pharmaceuticals Inc | 2023-08-23 | director & 10 percent owner & Chief Scientist |
Jonathan C Javitt Latest Holdings Summary
Jonathan C Javitt currently owns a total of 1 stock. Jonathan C Javitt owns 1,476,833 shares of NRX Pharmaceuticals Inc (NRXP) as of August 23, 2023, with a value of $2 Million.
Latest Holdings of Jonathan C Javitt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NRXP | NRX Pharmaceuticals Inc | 2023-08-23 | 1,476,833 | 1.30 | 1,919,883 |
Holding Weightings of Jonathan C Javitt
Jonathan C Javitt Form 4 Trading Tracker
According to the SEC Form 4 filings, Jonathan C Javitt has made a total of 3 transactions in NRX Pharmaceuticals Inc (NRXP) over the past 5 years, including 2 buys and 1 sells. The most-recent trade in NRX Pharmaceuticals Inc is the acquisition of 10,000 shares on August 23, 2023, which cost Jonathan C Javitt around $33,000.
Insider Trading History of Jonathan C Javitt
- 1
Jonathan C Javitt Trading Performance
GuruFocus tracks the stock performance after each of Jonathan C Javitt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jonathan C Javitt is 2.08%. GuruFocus also compares Jonathan C Javitt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jonathan C Javitt within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jonathan C Javitt's insider trading performs compared to the benchmark.
Performance of Jonathan C Javitt
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -12.4 | | | | | |
| Relative Return to S&P 500(%) | -10.32 | | | | | |
Jonathan C Javitt Ownership Network
Ownership Network List of Jonathan C Javitt
Ownership Network Relation of Jonathan C Javitt
Jonathan C Javitt Owned Company Details
What does Brainstorm Cell Therapeutics Inc do?
Who are the key executives at Brainstorm Cell Therapeutics Inc?
Jonathan C Javitt is the director of Brainstorm Cell Therapeutics Inc. Other key executives at Brainstorm Cell Therapeutics Inc include Chief Executive Officer Chaim Lebovits , EVP & Head Global Clin Research Stacy Lindborg , and Chief Medical Officer Kirk Taylor .
Brainstorm Cell Therapeutics Inc (BCLI) Insider Trades Summary
Over the past 18 months, Jonathan C Javitt made no insider transaction in Brainstorm Cell Therapeutics Inc (BCLI). Other recent insider transactions involving Brainstorm Cell Therapeutics Inc (BCLI) include a net purchase of 590,208 shares made by Chaim Lebovits , a net sale of 63,000 shares made by , and a net purchase of 11,500 shares made by Stacy Lindborg .
In summary, during the past 3 months, insiders sold 0 shares of Brainstorm Cell Therapeutics Inc (BCLI) in total and bought 23,836 shares, with a net purchase of 23,836 shares. During the past 18 months, 4,200 shares of Brainstorm Cell Therapeutics Inc (BCLI) were sold and 62,361 shares were bought by its insiders, resulting in a net purchase of 58,161 shares.
Brainstorm Cell Therapeutics Inc (BCLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Brainstorm Cell Therapeutics Inc Insider Transactions
Jonathan C Javitt Mailing Address
Above is the net worth, insider trading, and ownership report for Jonathan C Javitt. You might contact Jonathan C Javitt via mailing address: 1201 North Market Street, Suite 111, Wilmington De 19801.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
